Castle Biosciences CSTL
NASDAQ CSTL
$35.35 +0.36 (+1.03%)
As of: Sep 22, 2026 · 10:04 AM EDT

Castle Biosciences (CSTL) EBITDA (2018 - 2026)

Castle Biosciences' (CSTL) quarterly EBITDA came in at -$3.1 million in Q2 2026, up 27.78% year-over-year from -$2.4 million in Q2 2025, and up 83.32% quarter-over-quarter from -$18.4 million in Q1 2026.

Analysis

Castle Biosciences (CSTL) EBITDA (2018 - 2026) Analysis & Trends

Castle Biosciences has disclosed EBITDA across 9 years of filings, most recently posting -$3.1 million for Q2 2026.

  • In Q2 2026, EBITDA rose 27.78% year-over-year to -$3.1 million; the TTM figure through Jun 2026 stood at -$32.1 million (down 39.3% YoY), while the FY2025 annual figure was -$42.8 million, down 593.77% from the prior year.
  • EBITDA came in at -$3.1 million for Q2 2026 at Castle Biosciences, up from -$18.4 million in the prior quarter.
  • In the past five years, EBITDA ranged from a high of $5.1 million in Q3 2024 to a low of -$31.5 million in Q1 2023.
  • Average EBITDA over 5 years is -$10.9 million, with a median of -$6.2 million recorded in 2023.
  • Year-over-year, EBITDA sank 472.27% in 2022 and jumped 171.58% in 2024.
  • Over 5 years, EBITDA stood at -$22.8 million in 2022, then surged by 75.22% to -$5.7 million in 2023, then surged by 171.58% to $4.0 million in 2024, then slumped by 194.49% to -$3.8 million in 2025, then climbed by 19.78% to -$3.1 million in 2026.
  • Per Business Quant data, the three most recent EBITDA figures were -$3.1 million in Q2 2026, -$18.4 million in Q1 2026, and -$3.8 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA (Qtr)
1 Natera 53.05 Bn 51.95 Bn 486.15 Mn -75.79 Mn
2 Quest Diagnostics 27.19 Bn 26.87 Bn 1.03 Bn 459.00 Mn
3 Labcorp Holdings 25.93 Bn 25.81 Bn 1.11 Bn 451.60 Mn
4 Guardant Health 23.97 Bn 22.91 Bn 219.03 Mn -129.12 Mn
5 Tempus AI 13.64 Bn 12.82 Bn 274.25 Mn -75.91 Mn
6 Caris Life Sciences 8.47 Bn 7.68 Bn 182.38 Mn 26.93 Mn
7 Sotera Health 5.35 Bn 4.99 Bn 177.96 Mn 109.81 Mn
8 BillionToOne 4.96 Bn 4.41 Bn 77.11 Mn 5.50 Mn
9 Adaptive Biotechnologies 4.55 Bn 4.21 Bn 51.39 Mn -15.77 Mn
10 Castle Biosciences 1.08 Bn 811.36 Mn 79.85 Mn -3.07 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -3.07 Mn
Mar 31, 2026 -18.41 Mn
Dec 31, 2025 -3.83 Mn
Sep 30, 2025 -6.80 Mn
Jun 30, 2025 -4.25 Mn
Mar 31, 2025 -27.93 Mn
Dec 31, 2024 4.05 Mn
Sep 30, 2024 5.08 Mn
Jun 30, 2024 5.01 Mn
Mar 31, 2024 -5.47 Mn
Dec 31, 2023 -5.66 Mn
Sep 30, 2023 -9.64 Mn
Jun 30, 2023 -21.16 Mn
Mar 31, 2023 -31.52 Mn
Dec 31, 2022 -22.83 Mn
Sep 30, 2022 -21.54 Mn
Jun 30, 2022 -3.97 Mn
Mar 31, 2022 -24.52 Mn
Dec 31, 2021 -15.17 Mn
Sep 30, 2021 -11.81 Mn
API Access

Castle Biosciences EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda&ticker=CSTL&period=max&api_key=YOUR_API_KEY